Maria Fonseca, MD, Cristian Milla Matute, MD, Rene Aleman, MD, Tolga Erim, DO, Emanuele Lo Menzo, MD, PhD, FACS, FASMBS, Samuel Szomstein, MD, FACS, FASMBS, Raul J Rosenthal, MD, FACS, FASMBS. Cleveland Clinic Florida
There is no consensus on the ideal surgical treatment for medically refractory gastroparesis (GS). More evidence however exists on the benefits of pyloromyotomy. For diabetic patients with severe nausea, the use of implantable gastric stimulator has been demonstrated to be advantageous. We present the case of a 48-year-old female with long time history of refractory gastroparesis. She presents with generalized abdominal pain and multiple episodes of nausea and vomiting. Due to previous unsuccessful medical treatment and trial with Domperidone, the patient was offered a concomitant per-oral pyloromyotomy(POP) and laparoscopic gastric electric stimulator (GES) implantation. The patient recovered successfully after surgical intervention with no further complications.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 95476
Program Number: V061
Presentation Session: Exhibit Hall Theater Video Session II
Presentation Type: EHVideo